News | July 07, 2023
Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
The detailed terms in relation to the Rights Issue, including but not limited to the issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course.
Subscribe To Our Newsletter & Stay Updated
